Thomas Grotkjaer joined Novo Holdings in 2017 and is a Planetary Health Investments team partner. He also oversees the Nordic early-stage activities. Prior to joining Novo Holdings, Thomas worked in business development at Novozymes, where he introduced advanced yeast technology to the biofuel industry and built a portfolio of biochemical projects. Earlier in his career, he was part of the venture capital-backed start-up company Fluxome Sciences. He also held biotechnology research and process engineering positions at Toftejorg (now Alfa Laval) and the Carlsberg Breweries.
Thomas holds a PhD in Metabolic Engineering, an MSc in Chemical Engineering from the Technical University of Denmark, and a graduate diploma in Business Administration (Marketing Management and Finance) from Copenhagen Business School.
